United States v. North American Health Care, Inc.

173 F. Supp. 3d 943, 2016 WL 1182058, 2016 U.S. Dist. LEXIS 40594
CourtDistrict Court, N.D. California
DecidedMarch 28, 2016
DocketCase No. 14-cv-02401-WHO
StatusPublished

This text of 173 F. Supp. 3d 943 (United States v. North American Health Care, Inc.) is published on Counsel Stack Legal Research, covering District Court, N.D. California primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
United States v. North American Health Care, Inc., 173 F. Supp. 3d 943, 2016 WL 1182058, 2016 U.S. Dist. LEXIS 40594 (N.D. Cal. 2016).

Opinion

ORDER ON MOTION TO DISMISS

Re: Dkt. No. 84

WILLIAM H. ORRICK, United States District Judge.

Currently before me is defendant John Sorensen’s second motion to dismiss claims asserted by plaintiff relator John Orten under the federal False Claims Act (FCA). Pursuant to Civil Local Rule 7-l(b), this matter is appropriate for resolution without oral argument, and I hereby VACATE the March 30, 2016 hearing. Among several issues asserted in the motion, the public disclosure bar precludes Orten’s claim regarding “upcoding” and Orten’s failure to identify a Medicare statute or regulation that Sorensen violated that is a condition of payment makes meritless the “Star Ratings” claim. I grant in part and deny in part the motion to dismiss.

BACKGROUND

In my November 2015 Order, I dismissed Orten’s FCA cause of action based on “Star Rating” allegations with leave to amend because Orten failed to allege sufficient facts and to identify particular statutory or regulatory requirements that are conditions of payment. Dkt. No. 74 at 8.11 also dismissed his FCA cause of action based on “upcoding” with leave to amend, because Orten failed to make “explicit his NAHC upcoding allegations and to plead facts showing that Sorensen may be liable for that conduct and that the public disclosure bar does not apply.” Id. at ll.2 Finally, I dismissed with leave-to amend Orten’s conspiracy and state law FCA claims for failure to plead adequate facts. Id. at 11-12.

Orten filed his Third Amended Complaint on December 9, 2015. Sorensen again moves to dismiss the FCA claims based on Star Ratings and upcoding allegations, as well as the conspiracy and state law claims. Dkt. No. 84. The United States (the real party in interest) has filed a second “Statement of Interest,” explaining [947]*947its view that Orten’s upcoding allegations cannot form the basis of an FCA claim under the public disclosure bar. Dkt. No. 87.

LEGAL STANDARD

Under Federal Rule of Civil Procedure 12(b)(6), a district court must dismiss a complaint if it fails to state a claim upon which relief can be granted. To survive a Rule 12(b)(6) motion to dismiss, the plaintiff must allege “enough facts to state a claim to relief that is plausible on its face.” Bell Atl. Corp. v. Twombly, 560 U.S. 544, 556, 127 S.Ct. 1955, 167 L.Ed.2d 929 (2007). A claim is facially plausible when the plaintiff pleads facts that “allow the court to draw the reasonable inference that the defendant is liable for the misconduct alleged.” Ashcroft v. Iqbal, 556 U.S. 662, 678, 129 S.Ct. 1937, 173 L.Ed.2d 868 (2009) (citation omitted). There must be “more than a sheer possibility that a defendant has acted unlawfully.” Id.. While courts do not. require “heightened fact pleading of specifics,” a plaintiff must allege facts sufficient to “raise a right to relief above the speculative level.” Twombly, 550 U.S. at 555, 570, 127 S.Ct. 1955.

“Because they involve allegations of fraud, qui tam actions under the FCA must meet not only the requirement of Rule 8, but also the particularity requirements of Rule 9.” United States ex rel. Lee v. Corinthian Colls., 655 F.3d 984, 992 (9th Cir.2011): Under Federal Rule of Civil Procedure 9(b), a party must “state with particularity the circumstances constituting fraud or mistake,” including “the who, what, when, where, and how of the misconduct charged.” Vess v. Ciba-Geigy Corp. USA, 317 F.3d 1097, 1106 (9th Cir.2003) (internal quotation marks omitted). However, “Rule 9(b) requires only that the circumstances of fraud be stated with particularity; other facts may be pleaded generally, or in accordance with Rule 8.” United States ex rel. Lee v. Corinthian Colls., 655 F.3d at 992.

In decidinjg whether the plaintiff has stated a claim upon which relief can be granted, the Court accepts the plaintiffs allegations as true and draws all reasonable inferences in favor of the plaintiff. Usher v. City of Los Angeles, 828 F.2d 556, 561 (9th Cir.1987). However, the court is not required to accept as true “allegations that are merely eonclusoxy, unwarranted dedúctions of fact, or-unreasonable inferences.” In re Gilead Scis. Sec. Litig., 536 F.3d 1049, 1055 (9th Cir.2008).

DISCUSSION

I. FCA CAUSE OF ACTION

A. Upcoding

1. Ox-ten’s Allegations Regarding Upcoding and Sorensen’s Role

In the TAC, Orten makes explicit that his FCA claim is based in part on allegations that Sorensen engaged in “upcoding” to defraud the Medicare program. Specifically he adds new allegations that NAHC pushed employees to increase “Resource Utilization Group” (RUG) rates to maximize the reimbursements NAHC received from the government. TAC ¶ 28. A NAHC VP informed Orten (and other administrators) that NAHC had a company policy of “pushing the limit of maximizing Medicare reimbursement” by upcoding and using questionable and unnecessary therapies. Id. As part of that effort, NAHC pushed the use of “Accelerated Care Plus” (ACP) equipment, where there was no benefit to patients but a “windfall” in therapy minutes that NAHC could charge the government. Id. ¶ 29. These unnecessary and inappropriate therapies also included use of the “ACP bike.” Id. ¶30, Orten alleges that he was also aware of the -pervasive practice of RUG upcoding for “Activities of Daily- Living” (ADLs), because the same [948]*948NAHC VP taught “Minimum Data Set” (MDS) coding during administrator and MDS nurse meetings where Orten was present. Id. ¶ 31. The NAHC VP taught staff to always code a two-person assist for various activities regardless of whether it was necessary for the ADL, a practice which resulted in inflated rates and was inconsistent with the NAHC Residential Assessment Instrument (RAI) manual. Id.

Orten alleges that NAHC continued to perform unnecessary therapy on residents, and thereby engaged in RUG upcoding, after the March 10, 2010 Washington Post article that identified NAHC as a target of a government investigation into upcoding. Id. He asserts that Sorensen was personally involved in the upcoding both before and after the Washington Post article, and actively encouraged the fraud by instructing staff to perform unnecessary treatments that would allow maximum billing with minimal cost to NAHC. Id. ¶ 32. He states that Sorensen worked with unnamed individuals outside of NAHC, including unnamed doctors and administrators, to accomplish his goals. Id.

2. Public Disclosure Bar

Under the current version of the FCA, the public disclosure bar precludes a claim:

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Bell Atlantic Corp. v. Twombly
550 U.S. 544 (Supreme Court, 2007)
Ashcroft v. Iqbal
556 U.S. 662 (Supreme Court, 2009)
KRUPSKI v. COSTA CROCIERE S. P. A
560 U.S. 538 (Supreme Court, 2010)
US Ex Rel. Baltazar v. Warden
635 F.3d 866 (Seventh Circuit, 2011)
United States v. Corinthian Colleges
655 F.3d 984 (Ninth Circuit, 2011)
Vess v. Ciba-Geigy Corp. USA
317 F.3d 1097 (Ninth Circuit, 2003)
In Re Gilead Sciences Securities Litigation
536 F.3d 1049 (Ninth Circuit, 2008)
August Bogina, III v. Medline Industries, Incorpora
809 F.3d 365 (Seventh Circuit, 2016)
United States v. Pfizer, Inc.
9 F. Supp. 3d 34 (D. Massachusetts, 2014)
United States ex rel. Fryberger v. Kiewit Pacific Co.
41 F. Supp. 3d 796 (N.D. California, 2014)

Cite This Page — Counsel Stack

Bluebook (online)
173 F. Supp. 3d 943, 2016 WL 1182058, 2016 U.S. Dist. LEXIS 40594, Counsel Stack Legal Research, https://law.counselstack.com/opinion/united-states-v-north-american-health-care-inc-cand-2016.